He Liang Fu
Presidente presso JIANGSU AIDEA PHARMACEUTICAL CO., LTD.
Patrimonio netto: 3 M $ in data 30/04/2024
Profilo
He Liang Fu is currently the Chairman at Jiangsu Aidea Pharmaceutical Co., Ltd.
He previously held the position of President at Techpool Bio-Pharma Co., Ltd.
and was a Professor at Sun Yat-Sen University.
He obtained his undergraduate degree from Nanjing University in 1989.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
29/12/2022 | 1 167 600 ( 0.23% ) | 2 M $ | 30/04/2024 | |
30/08/2022 | 721 283 ( 0.33% ) | 1 M $ | 30/04/2024 |
Posizioni attive di He Liang Fu
Società | Posizione | Inizio |
---|---|---|
JIANGSU AIDEA PHARMACEUTICAL CO., LTD. | Presidente | 01/01/2014 |
Precedenti posizioni note di He Liang Fu
Società | Posizione | Fine |
---|---|---|
Sun Yat-Sen University | Corporate Officer/Principal | - |
Techpool Bio-Pharma Co., Ltd.
Techpool Bio-Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Techpool Bio-Pharma Co., Ltd. researches, develops, manufactures, and markets bio-pharmaceutical products. Its products include Techpool Roan, Kailikang, Bondronat and Roxin. The firm specializes in the sales, research and development, and production of biopharmaceuticals in critical care. The company was founded in 1993 and is headquartered in Guangzhou, China. | Presidente | - |
Formazione di He Liang Fu
Nanjing University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
JIANGSU AIDEA PHARMACEUTICAL CO., LTD. | Health Technology |
Aziende private | 1 |
---|---|
Techpool Bio-Pharma Co., Ltd.
Techpool Bio-Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Techpool Bio-Pharma Co., Ltd. researches, develops, manufactures, and markets bio-pharmaceutical products. Its products include Techpool Roan, Kailikang, Bondronat and Roxin. The firm specializes in the sales, research and development, and production of biopharmaceuticals in critical care. The company was founded in 1993 and is headquartered in Guangzhou, China. | Health Technology |
- Borsa valori
- Insiders
- He Liang Fu